Sofie Biosciences Scores $1.5M In SBIR

Culver City-based Sofie Biosciences has scored a $1.5M, Phase II SBIR award for its Positron Emission Tomography (PET) imaging technology, the company said Thursday. The company said the SBIR award came from the National Cancer Institute (NCI). The company--which is developing PET probes, scanners, and chemistry systems, said the contract will support further development of its products. Sofie Biosciences is led by Patrick Phelps. The company is venture backed by Tata Industries, MRM Capital and the Cycad Group.